文献速递主动脉疾病外周动脉疾病

血管腔内技术时代复杂主髂动脉闭塞性病变开放手术修复的长期结局

Long-Term Outcomes of Open Surgical Repair for Complex Aortoiliac Occlusive Disease in the Age of Endovascular Advancements.
PubMed 文献 · Ann Vasc Surg · 2025-03-24

单中心回顾性分析2010年1月至2020年12月76例因TASC II D型主髂动脉闭塞性病变行开放手术修复的患者,择期手术49例、急诊手术27例。择期组30天死亡率为0%(0/49),急诊组为19%(5/27)(P<0.01);择期组1、2、3、5年生存率分别为98%、96%、94%、86%,急诊组分别为78%、62%、62%、62%(P=0.30)。结论认为开放修复对复杂主髂动脉闭塞性病变可获得持久结局,择期病例死亡率低、保肢率和移植物通畅率高。

要点

  • 择期开放修复复杂TASC II D型主髂动脉闭塞性病变30天死亡率为0%(0/49),急诊组为19%(5/27)(P<0.01)。
  • 择期组1、2、3、5年移植物通畅率分别为96%、90%、90%、85%。
  • Rutherford分级中位术前3级改善至术后0级(P<0.001),61例中59例(97%)ABI维持≥0.9。

核心结论

  • 开放修复复杂主髂动脉闭塞性病变可获得持久结局,择期病例死亡率低、保肢率和移植物通畅率高;未来研究应探索长期比较结局。

研究设计与样本

  • 单中心回顾性分析,纳入2010年1月至2020年12月接受开放主髂动脉闭塞性病变修复的患者76例(男性61%,平均年龄62±10岁),均为TASC II D型病变。
  • 外周动脉疾病及既往干预常见(67例,88%);择期手术49例(64%),急诊手术27例(36%)。

主要发现

  • 30天死亡率:择期组0%(0/49)vs 急诊组19%(5/27)(P<0.01)。
  • 1、2、3、5年生存率:择期组98%(48/49)、96%(47/49)、94%(46/49)、86%(42/49)vs 急诊组78%(21/27)、62%(17/27)、62%(17/27)、62%(17/27)(P=0.30)。
  • 择期组1、2、3、5年移植物通畅率分别为96%(47/49)、90%(44/49)、90%(44/49)、85%(42/49)。
  • Rutherford分级中位术前3级改善至术后0级(P<0.001);61例中59例(97%)ABI维持≥0.9。
  • 血管并发症39例(51%),再干预12例(16%);中位随访59个月持续保肢。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aortoiliac occlusive disease (AIOD) may lead to critical limb ischemia, requiring revascularization. Open repair remains preferred for complex type C and D lesions despite endovascular options. This study evaluated long-term outcomes of open surgical repair in acute and chronic AIOD. METHODS: A single-centre, retrospective analysis was conducted on patients undergoing open AIOD repair (January 2010-December 2020). Primary outcomes included 30-day and long-term mortality; secondary outcomes were graft patency, Rutherford classification improvement, and limb salvage. RESULTS: Seventy-six patients (61% male; mean age 62 ± 10 years) underwent open repair for Trans-Atlantic Inter-Society Consensus (TASC) II type D AIOD. Peripheral arterial disease and prior interventions were common (67 patients, 88%). Elective surgery was performed in 49 patients (64%), while 27 patients (36%) underwent urgent procedures. The 30-day mortality rate was 0% (0/49) for elective cases but 19% (5/27) for urgent cases (P < 0.01). Long-term survival rates at 1, 2, 3, and 5 years were 98% (48/49), 96% (47/49), 94% (46/49), and 86% (42/49) for elective cases versus 78% (21/27), 62% (17/27), 62% (17/27), and 62% (17/27) for urgent cases (P = 0.30), respectively. Elective cases demonstrated high graft patency at 1, 2, 3, and 5 years (96% [47/49], 90% [44/49], 90% [44/49], and 85% [42/49]), respectively. Rutherford classification improved significantly (median preoperative stage 3 to postoperative stage 0, P < 0.001), with stable ankle-brachial index (ABI) values (≥0.9) in 59 of 61 patients (97%). Vascular complications occurred in 39 patients (51%), with reinterventions in 12 patients (16%). Sustained limb salvage was observed over long-term follow-up (median 59 months). CONCLUSION: Open repair for complex AIOD offers durable outcomes, with low elective case mortality and high limb salvage and graft patency. Future studies should explore long-term comparative outcomes.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Makaloski V, Ilcheva L, Valcheva-Ilieva S, et al. Long-Term Outcomes of Open Surgical Repair for Complex Aortoiliac Occlusive Disease in the Age of Endovascular Advancements. Ann Vasc Surg. 2025. PMID: 40139429. doi:10.1016/j.avsg.2025.03.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。